Terms: = Pancreatic cancer AND EIF3E, eIF3-p46, 3646, ENSG00000104408, EIF3S6, eIF3e, EIF3-P48, INT6 AND Prognosis
3 results:
1. Pathological validation and prognostic potential of quantitative MRI in the characterization of pancreas cancer: preliminary experience.
Klaassen R; Steins A; Gurney-Champion OJ; Bijlsma MF; van Tienhoven G; Engelbrecht MRW; van Eijck CHJ; Suker M; Wilmink JW; Besselink MG; Busch OR; de Boer OJ; van de Vijver MJ; Hooijer GKJ; Verheij J; Stoker J; Nederveen AJ; van Laarhoven HWM
Mol Oncol; 2020 Sep; 14(9):2176-2189. PubMed ID: 32285559
[TBL] [Abstract] [Full Text] [Related]
2. Perioperative Blood Transfusion and the prognosis of pancreatic cancer Surgery: Systematic Review and Meta-analysis.
Mavros MN; Xu L; Maqsood H; Gani F; Ejaz A; Spolverato G; Al-Refaie WB; Frank SM; Pawlik TM
Ann Surg Oncol; 2015 Dec; 22(13):4382-91. PubMed ID: 26293837
[TBL] [Abstract] [Full Text] [Related]
3. Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic.
Ranieri G; Patruno R; Ruggieri E; Montemurro S; Valerio P; Ribatti D
Curr Med Chem; 2006; 13(16):1845-57. PubMed ID: 16842197
[TBL] [Abstract] [Full Text] [Related]
